Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US5708163A · kind A · utility
4Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 1995 |
| Grant date | Jan 13, 1998 |
| Priority date | — |
| Expiry date | Apr 28, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a process for synthesizing a compound having the structure: ##STR1## wherein R is H, as well as related oligosaccharides useful as a vaccine for inducing antibodies to human breast cancer cells in an adjuvant therapy therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.